. 2007 May 12;299(3):111–138. doi: 10.1007/s00403-007-0744-y

Table 20.

Laboratory controls during treatment with MTX [137]

graphic file with name 403_2007_744_Tab6_HTML.jpg

^aHb, HCT, erythrocytes, leukocytes, differential blood count, platelets

^bALT, AST, AP, γGT, albumin, bilirubin, lactate dehydrogenase (LDH)

^cLiver biopsy instead of a liver sonography in risk groups